據報內地嬰幼兒配方奶粉新國家標準最快年底出台
據《第一財經》報道,於今年6月18日,國家衛健委就嬰幼兒配方奶粉新的國家標準進行了內部再次徵求建議。有奶粉企業透露,雖然新國標還在徵求意見,但主管部門已在鼓勵企業按照新國標徵求意見稿,進行配方研究生產和後期試驗,並鼓勵、認可企業在新國標發布之前做的試驗數據。如此看來,說明新國標的指標已基本確定,今年年底或明年年初出台的可能性很大。
多位乳企負責人認為,新國標一旦落地,對於行業的影響將不亞於配方註冊制。嬰幼兒奶粉配方註冊制也被稱為「史上最嚴新政」,讓國內的奶粉品牌數從3,000多個減少到目前的1,000多個。
據報國家衛生健康委員會於2018年9月公布了嬰配粉新的國家標準並公開徵求意見,新國標增加了對部分營養素的規定,對蛋白和乳糖的比例做出更明確要求;同時對維生素、菸酸、葉酸,以及鈉、鉀、銅等營養素的用量的上下限,進行了嚴格的規定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.